Navigation Links
Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
Date:7/29/2008

RICHMOND, Calif., July 29 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic development programs and an overview of the company's business strategy at 3:00 p.m. (ET) on Tuesday, August 5, 2008, at the BMO Capital Markets Focus on Healthcare Conference in New York City.

The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy. Other therapeutic development programs are focused on stem cell mobilization, ALS, cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF(TM)) that can control gene expression and, consequently, cell function. Sangamo is also developing sequence-specific ZFP Nucleases (ZFN(TM)) for gene modification. Sangamo has established
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
2. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
3. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
4. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
5. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
6. Sangamo BioSciences to Present at the Canaccord Adams Diabetes and Obesity Conference
7. Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
8. Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors
9. Sangamo BioSciences Announces First Quarter Conference Call and Webcast
10. Sangamo BioSciences Announces License Agreement For the Use of ZFP Technology For Generation of Transgenic Animals
11. Sangamo BioSciences to Present at the Cowen and Company 28th Annual Health Care Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ewswire-Asia-FirstCall/ -- Yongye International, I... leading manufacturer, developer,and distributor o...ucts in the,People,s Republic of China (PRC), toda... at 10:00 a.m. Eastern Time (11:00 p.m. Beijing Ti...s for the quarter ended September 30, 2009. ,...
(Date:11/9/2009)...ewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Am...enthal, Professor of Immunology and Microbiology o...ne and Pharmacy, reported on work conducted in col... and CEL-SCI on CEL-SCI,s LEAPS vaccine technology...e: "All Things Considered" Conference in Crystal C...
(Date:11/8/2009)... Nov. 5, 2009 Complete Genomics, a third-generat...ed publication of a report in the journal Science...rm, including analysis of sequence data from three...these three genomes sequenced on the proof-of-prin...r 87x coverage to $1,726 for 45x coverage for the ...
(Date:11/6/2009)...RNewswire/ -- Myriant Technologies LLC ("Myriant")...urer of renewable bio-chemicals, Uhde Corporation...Uhde GmbH, one of the world,s leading engineering ...e for the engineering, procurement & construct...ts based on renewable feedstocks. The execution o...
Breaking Biology Technology:Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 3CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3
... Diagnostics, a,genomics-based diagnostics company...a Commonwealth University School of Medicine has i...TM) Tissue of Origin Test. The new,genomics-based ...n so that,tissue-specific management can begin. VC...n the country to evaluate this leading technology ...
...Nov. 6 Centocor,Inc., Schering-Plough Corporation...ed today that an estimated one million patients ha... the leading anti-tumor necrosis,factor (TNF)-alph...ed to,treat more patients worldwide than all other...first anti-TNF-alpha treatment approved by the,U.S...
...logical Threats Receives Government ... ICx Technologies, a developer of,advanced techno... announced,today a contract award to procure its A...n of airborne biological threats. The AirSentinel,...dvanced Research Projects,Agency (DARPA) and the D...
Other Biology Technology:Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics' Tissue of Origin Test Designed to Aid in Determination of a Tumor's Origin 2Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics' Tissue of Origin Test Designed to Aid in Determination of a Tumor's Origin 3Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics' Tissue of Origin Test Designed to Aid in Determination of a Tumor's Origin 4REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 2REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 3REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 4REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 5REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 6REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 7REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 8REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 9REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 10REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 11REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 12ICx Awarded Department of Defense Contract for AirSentinel Monitors 2
(Date:11/8/2009)..., WEST LAFAYETTE, Ind. - Researchers at Purdue Un...ing damaged nerve fibers in spinal cord injuries u...blood shortly after an accident. , The synthetic...out 60 nanometers in diameter, or roughly 100 time..., Researchers have been studying how to deliver d...
(Date:11/6/2009)...To celebrate the 150th anniversary this month of t...erican Institute of Biological Sciences (AIBS) is ...about Charles Darwin and his historic insights int...an of the University of California, Berkeley, and ...ian,s article, "Ten Myths About Charles Darwin," a...
(Date:11/5/2009)...The National Association of Biology Teachers (NABT...f biological sciences at Naugatuck Valley Communit...he 2009 Evolution Education Award during the NABT ...eld 11-14 November 2009 in Denver, Colorado. , T... American Institute of Biological Sciences,(AIBS)...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Biologists, educators recognize excellence in evolution education 2Dietary supplements manufacturers gain new tool to help ensure quality products 9150 1Dietary supplements manufacturers gain new tool to help ensure quality products 9150 2Providence Service Corporation Does Not Expect California Budget Issues to Materially Impact Its Business in the State 50992 1Providence Service Corporation Does Not Expect California Budget Issues to Materially Impact Its Business in the State 50992 2June 2009 Mayo Clinic Womens HealthSource Highlights Summer Skin Problems Low Vision and Pilates 4696 1June 2009 Mayo Clinic Womens HealthSource Highlights Summer Skin Problems Low Vision and Pilates 4696 2June 2009 Mayo Clinic Womens HealthSource Highlights Summer Skin Problems Low Vision and Pilates 4696 3June 2009 Mayo Clinic Womens HealthSource Highlights Summer Skin Problems Low Vision and Pilates 4696 4June 2009 Mayo Clinic Womens HealthSource Highlights Summer Skin Problems Low Vision and Pilates 4696 5
... the number of living species on earth range from ...n species have been classified and described. Esti...ord is an even more daunting task. , One tool ecol...lly relied on to identify patterns of existing bio...umb called the species-area effect: the tendency f...
...ering crowd of various species of bacteria is esse...ts of their chemical conversation are almost unive...t bacteria of different species can talk to each o...pecies can manipulate the conversation to confuse ...misdirection could have important consequences for...
...suggests that medications commonly referred to as ...ack a gene called the estrogen receptor beta. The ...ovulation rates in mice that were genetically engi...n receptor beta is one of two estrogen receptor pr...nes and are present throughout the female reproduc...
Other Biology News:Space matters: Estimating species diversity in the fossil record 2Say what? Bacterial conversation stoppers 2Say what? Bacterial conversation stoppers 3New Discovery May Help Doctors Treat Infertility 2New Discovery May Help Doctors Treat Infertility 3
HP Guaranteed siRNA from QIAGEN
...ells are used for heterologous protein expression ...S2 cell line was derived from a primary culture of...ster embryos (1). This versatile cell line grows...sily adapted to suspension culture. S2 cells are ...
...ression vectors, we in-troduced a new concept, nam...) at tran-scriptional level at the T7 phage promot...fying the plasmid copy number, The main advantage ... retains practically all of the outstanding featur...
...or NTI allows you to store and manage very large a...al relational database. Storing and managing data ...ne tracking and enables you to locate your data ea...egrates seamlessly with Invitrogen's desktop seque...
Biology Products: